Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021. Benzinga · Nov 10, 2022
Clever Leaves To Grow & Commercialize House Of Kush THC Flower For International Cannabis Markets Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) entered into partnership with House of Kush, to be the exclusive grower and distributor of proprietar Benzinga · Sep 21, 2022
EXCLUSIVE: Colombia Is About To Legalize Cannabis - And Exports May Land On Your Doorstep Soon, This CEO Says Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States. Benzinga · Aug 9, 2022
Are Nasdaq-Traded Colombian Cannabis Stocks Worth Buying? Yes And No, Says Analyst Cantor Fitzgerald's analyst Pablo Zuanic initiated coverage on two cannabis companies on Monday: Flora Growth Corp. (NASDAQ: FLGC) and Clever Leaves Holdings Inc (NASDAQ: CLVR) Benzinga · Aug 1, 2022
Cantourage And Clever Leaves Intensify Partnership For Distribution Of Medical Cannabis In Germany Cantourage GmbH and Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) have continued to intensify their strategic partnership for the distribution of medical cannabis flowers throughout Germany. Benzinga · Jun 8, 2022
3 Cannabis Stocks That Have Plunged More Than 55% in 2022 The outlook for the cannabis industry is brightening due to the overwhelming demand for it to treat several diseases. However, the uncertainty surrounding the legalization of cannabis at the federal level, and renewed concerns related to the health implications of its use, have caused many companies to suffer a retreat.… StockNews.com · May 20, 2022
Clever Leaves Reports First Quarter 2022 Results: Revenue Increases 50% To $5.2M Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the first quarter en Benzinga · May 13, 2022
Clever Leaves Affiliate Now Fully Licensed To Distribute Medical Cannabis In Germany Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) and its affiliate in Germany, Clever Leaves Germany GmbH, have received all of the required regulatory licenses, per Benzinga · Apr 27, 2022
Clever Leaves Partners With Biom Therapeutics As Supplier Of Pharmaceutical-Grade CBD Used In Clinical Trials Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), announced a two-year supply agreement with American, clinical-stage bio-pharmaceutical company, Biom Therapeutics to provide Benzinga · Apr 20, 2022
Why Is Clever Leaves Stock Surging 140%? Look To Washington DC Next Week For The Answer Stocks of Clever Leaves Holdings Inc. (NASDAQ: CLVRW) are soaring as of late Friday following reports indicating the U.S. Benzinga · Mar 25, 2022
Why Clever Leaves Stock Is Trading Higher And What Investors Need To Know Clever Leaves Holdings Inc (NASDAQ: CLVR) is trading higher Friday following reports indicating the U.S. House Rules Committee has scheduled a Monday afternoon meeting to prepare a federal marijuana legalization bill for floor action. Benzinga · Mar 25, 2022
34 Stocks Moving in Friday's Pre-Market Session Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22 guidance. Benzinga · Mar 25, 2022
Clever Leaves Reports Fourth Quarter And Full Year 2021 Results Clever Leaves Holdings Inc. (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported late Thursday its financial and operating results for the fourth quarter and full-year ended December 31, 2021. Benzinga · Mar 24, 2022
Here's Why Cannabis-Related Stock Clever Leaves Is Rising During Thursday's After-Hours Session Clever Leaves Holdings Inc (NASDAQ: CLVR) shares are trading higher by 9.5% to $1.73 during Thursday's after-hours session after the company reported better-than-expected fourth-quarter sales results and reaffirmed FY22 guidance. Benzinga · Mar 24, 2022